Mikihiro Fujiya Selected Research

Mikihiro Fujiya Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 08/2002
15	Inflammation (Inflammations) 01/2022 - 04/2006
12	Ulcerative Colitis 04/2024 - 04/2006
12	Crohn Disease (Crohn's Disease) 01/2024 - 04/2006
10	Stomach Neoplasms (Stomach Cancer) 03/2024 - 08/2002
10	Colitis 01/2021 - 01/2010
9	Adenocarcinoma 03/2024 - 01/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 08/2002
8	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 06/2008
7	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 04/2012
7	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2003
6	Infections 07/2023 - 03/2009
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2010
6	Iron Overload 03/2017 - 11/2011
5	Hemorrhage 05/2024 - 10/2011
5	Carcinoma (Carcinomatosis) 03/2024 - 04/2006
5	Non-alcoholic Fatty Liver Disease 10/2023 - 08/2014
4	Fibrosis (Cirrhosis) 01/2018 - 08/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 01/2016
3	Cholangitis 02/2024 - 06/2019
3	Pathologic Constriction (Stenosis) 03/2022 - 08/2002
3	Hypersensitivity (Allergy) 01/2022 - 08/2017
3	Liver Diseases (Liver Disease) 01/2022 - 01/2015
3	Hypoxia (Hypoxemia) 01/2022 - 08/2010
3	Carcinogenesis 01/2021 - 03/2009
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Necrosis 04/2024 - 10/2023
2	Esophageal Neoplasms (Esophageal Cancer) 03/2024 - 06/2021
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024 - 06/2021
2	Weight Loss (Weight Reduction) 03/2024 - 02/2010
2	Sarcoidosis (Schaumann Disease) 01/2024 - 10/2021
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2023 - 01/2020
2	Lymphoma (Lymphomas) 09/2022 - 07/2011
2	Gastritis 07/2022 - 10/2021
2	Diarrhea 01/2022 - 02/2010
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2021
2	Diverticular Diseases 01/2022 - 08/2015
2	Chemical and Drug Induced Liver Injury 01/2022 - 06/2019
2	Wounds and Injuries (Trauma) 11/2021 - 07/2015
2	Ascites 08/2021 - 08/2017
2	Neoplasms, Cystic, Mucinous, and Serous 12/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 10/2022 - 06/2008
11	IronIBA 07/2017 - 03/2011
9	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 08/2021 - 03/2009
6	CytokinesIBA 08/2014 - 04/2006
5	FerrichromeIBA 03/2024 - 10/2016
5	SteroidsIBA 10/2023 - 01/2019
5	Infliximab (Remicade)FDA Link 01/2023 - 01/2013
5	Small Interfering RNA (siRNA)IBA 10/2022 - 06/2013
5	PolyphosphatesIBA 11/2021 - 08/2015
5	Dextrans (Dextran)FDA Link 11/2018 - 11/2011
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2018 - 11/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2023 - 04/2006
4	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 10/2022 - 11/2015
4	Immune Checkpoint InhibitorsIBA 07/2022 - 06/2020
4	MucinsIBA 01/2022 - 01/2003
4	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2015
4	Dextran SulfateIBA 01/2021 - 01/2010
3	NivolumabIBA 01/2022 - 01/2019
3	Capsules (Microcapsules)IBA 01/2022 - 08/2010
3	MicroRNAs (MicroRNA)IBA 11/2021 - 06/2013
3	AntibodiesIBA 07/2021 - 07/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 04/2010
3	RibonucleoproteinsIBA 06/2020 - 11/2015
3	Antimicrobial PeptidesIBA 11/2018 - 01/2010
3	Indicators and Reagents (Reagents)IBA 11/2017 - 12/2015
3	HepcidinsIBA 03/2017 - 02/2014
3	Cadherins (E-Cadherin)IBA 09/2013 - 01/2004
2	carbazochrome (Adona)IBA 05/2024 - 10/2022
2	Ustekinumab (CNTO 1275)FDA Link 04/2024 - 10/2020
2	vedolizumabIBA 04/2024 - 07/2023
2	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2021
2	Long Noncoding RNAIBA 02/2024 - 01/2021
2	Bevacizumab (Avastin)FDA Link 09/2023 - 12/2022
2	atezolizumabIBA 09/2023 - 12/2022
2	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 11/2021
2	Hemoglobins (Hemoglobin)IBA 05/2023 - 07/2017
2	Immunologic Factors (Immunomodulators)IBA 11/2022 - 01/2013
2	heptelidic acidIBA 01/2022 - 01/2021
2	Biosimilar PharmaceuticalsIBA 01/2022 - 10/2021
2	CateninsIBA 01/2022 - 01/2017
2	CT-P13IBA 01/2022 - 10/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2021 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2021 - 01/2020
2	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 01/2021 - 03/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2021 - 01/2011
2	Codon (Codons)IBA 06/2020 - 08/2002

Therapy/Procedure

28	Therapeutics 03/2024 - 01/2003
11	Drug Therapy (Chemotherapy) 05/2023 - 08/2002
4	Gastrectomy 01/2021 - 09/2008
3	Blood Component Removal (Apheresis) 01/2024 - 08/2021
3	Remission Induction 01/2024 - 08/2021
3	Radiotherapy 05/2023 - 01/2020
3	Chemoradiotherapy 01/2021 - 08/2016
2	Gastrostomy 03/2022 - 03/2011
2	Ligation 01/2022 - 01/2022
2	Molecular Targeted Therapy 11/2021 - 11/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 08/2016